Researchers at the University of Gothenburg, Sweden, in collaboration with colleagues in China, have discovered an antibody-like ... "We have identified a small molecule that binds to the virus's ...

Professor Terence Rabbits’ laboratory focuses on developing technologies using intracellular antibody fragments and small molecule derivatives, mainly aimed at targeting chromosomal translocation ...

Another reason for choosing a particular modality is that it is a team’s specialty. Strategic choices can be less about determining which modality best fits a potential target than about choosing a ...

Presentations will be delivered by experts from a wide variety of leading research groups including Pfizer, GSK, and Bio-Techne, along with co-hosts IPA, ACROBiosystems, and Curia. SALT LAKE CITY, ...

BenevolentAI has entered a two-year agreement with the MRC Technology to investigate new small molecule and antibody drug candidates. The UK-based artificial intelligence company has teamed up ...

South Korea-based biotech firms 1ST Biotherapeutics and LigaChem Biosciences (Kosdaq: 141080) have entered a strategic ...

Immunovant is developing batoclimab, a monoclonal antibody currently in a Phase IIa trial (NCT05907668 ... In addition to Merida and Immunovant, Biohaven is developing BHV-1300, a small molecule ...

Expanded collaboration leverages complementary expertise to unlock next-generation oncology therapeutics Focus on breakthrough ADC payloads and ...

Schrödinger, Inc. (Nasdaq: SDGR) strongly supports the U.S. Food and Drug Administration’s (FDA) plan to reduce, refine or ...

Shares of Skye Bioscience rose after the company announced promising preclinical data for a drug combination including its new CB1 antibody nimacimab. The stock was up 60% to $2.09 Tuesday. Shares ...

ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid ...